Small Cap Feast
Small Cap Feast – 05 February 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 914
Total number of AIM Companies trading: 847*
* As at 24 January 2019
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 89*
Total number of NEX Growth Market Companies trading: 87*
* As at 24 January 2019
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 145*
Total number of Standard List Companies trading: 128*
* As at 24 January 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Premium)
“Potential” intention to float from DWF, a global legal business. HY Oct 18 revenue of £133.4m.
Main Market (Specialist Funds)
The Global Sustainability Trust -aiming for attractive risk-adjusted returns by investing primarily in private market investments that are expected to have a positive environmental and social impact raising c.£200m. Due 31 Jan 2019.
United Oil & Gas (UOG.L) an oil and gas exploration and development company brought to the Official List (Standard Segment) in July 2017 by way of a reverse takeover of Senterra Energy plc. No capital to be raised, expected market cap of £17m and expected 28 Feb
Techniplas –global producer and support services company providing highly engineered and technically complex components, making the supply chain to original equipment manufacturers more efficient. FYDec17 rev $515m.
Speculation and Rumours
Bharti Airtel—Press reports of plans of a £6bn London IPO for India’s number two mobile operator.
Safestay (SFE.L) 83.95p £69.5m
Safestay, the owner and operator of an international brand of contemporary hostels, provided the following trading update for the 12 months to 31 Dec 2018.
Positive trading performance
39% increase in total revenues to £14.6m (2017: £10.5m)
Growth in Occupancy to 75.6% (2017: 72.8%)
Expect to deliver at least £3.4m in EBITDA (2017: £3.2m)
Added new hostel sites in Barcelona, Brussels and Vienna
Successful £10.36m capital raise in Dec 2018 to fund future expansion
Poised for European roll-out with 15 European cities identified
ECO Animal Health (EAH.L) 465p £313.2m
ECO Animal Health, a wholly owned subsidiary of ECO Animal Health Group, announced that it has entered a second worldwide exclusive licensing deal with the Poultry Diagnostic & Research Center, College of Veterinary Medicine at the University of Georgia (UGA).
This deal, which follows on from the one leading to the development of potential vaccines in the field of Mycoplasma gallisepticum, allows ECO to further develop, register and commercialize a live attenuated Mycoplasma synoviae vaccine for poultry developed by UGA. University researchers have concluded preliminary proof of concept efficacy and safety studies with this vaccine.
Water Intelligence (WATR.L) 395p £54.8m
Water Intelligence, a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions for both potable and non-potable water announced a series of corporate transactions that reinforce its growth trajectory for 2019 and beyond.
Acquisition of Ontario (Niagara), Canada franchise, expanding corporate presence into Canada and Upstate New York
Sale of a new franchise territory for Youngstown, Ohio (US)
Financial support to an Idaho (US) franchise accelerating expansion into municipal offerings
Formal launch of ORCA municipal sewer product into the United States following trials at a UK water utility
BlueRock Diamonds (BRD.L) 0.36p £1.44m
BlueRock Diamonds, the diamond producer, which owns and operates the Kareevlei Diamond Mine in the Kimberley region of South Africa, announced the recovery of an exceptional 8.97 carat diamond on 1 Feb.
This will be the third stone independently valued in excess of $50,000 mined from Kareevlei; the two previous record value stones were a 7.76 carat stone recovered in 2017 and sold for $10,070 per carat and a 10.58 carat stone recovered in 2018 and sold for $7,047 per carat.
TP Group (TPG.L) 6.5p £48.32m
TP Group, the specialist services and engineering group, announced an order worth c.£1.2m by the MOD to provide Extendair® Lithium Hydroxide Curtains for management of localised Carbon Dioxide contamination on board submarines. This order is placed as part of the estimated £22m framework contract previously entered into between TP Group and the MOD to manage equipment availability and spares provision for air purification systems, as announced by the Company on 3 April 2017. The order will be delivered by Micropore Inc., TP Group’s strategic partner in the United States, as announced on 24 May 2018.
The Micropore product complements the MOD’s existing Carbon Dioxide removal products to support additional operating conditions and to offer emergency backup to other systems in the event of failure. The products are expected to be delivered to the MOD in early 2019.
Carpetright (CPR.L) 20.8p £64.71m
Carpetright, Europe’s leading specialist carpet and floor coverings retailer, announced a trading update for the 13 week period to 26 Jan 2019.
The Group’s overall performance remains in line with expectations
As anticipated UK like-for-like sales remained negative for the period, although the trend has improved from that of the first half. Trading patterns have remained volatile week to week, against a backdrop of uncertainty and weak consumer confidence
Trading in the Rest of Europe has been tracking consistently ahead of the same period last year, driven by a strong performance in the Netherlands
We remain on target to achieve the £19m of annualised cash savings announced as part of the recapitalisation of the Group in May 2018
Landore Resources (LND.L) 1.05p £9.94m
Landore Resources provided results of the Phase 1 of a Detailed Metallurgical Assessment of the BAM Gold Deposit, Junior Lake Property, Ontario, Canada.
Landore Resources engaged Allard Engineering Services LLC of Tucson, Arizona, USA to provide services for the design and supervision of a Detailed Metallurgical Assessment of the BAM Gold Project. The Scoping level test work programme was designed to select a suitable process route for the BAM Gold Deposit mineralised material.
98% extraction of gold is achievable with conventional milling, grinding to 100% passing 212 micron followed by gravity separation (+65%) and cyanide leaching.
Reagent consumption was very low with Cyanide Consumption at ±0.40 kg/t and
Lime Consumption at ±0.60 kg/t. Heap leaching with fine crushing and agglomeration can achieve acceptable extractions of gold (±84% at test conditions).
The results from the Metallurgical studies, will be incorporated into the Preliminary Economic Assessment (PEA) scheduled for completion in Feb 2019.
Tristel (TSTL.L) 292.5p £129.59m
Tristel, the manufacturer of infection prevention and contamination control products utilising proprietary chlorine dioxide chemistry, announced the appointment of Dr. Bruno Holthof to its Board as a NED.
Dr. Bruno Holthof is the CEO of Oxford University Hospitals. Before OUH, he was CEO of the Antwerp Hospital Network from Jan 2004 until Sept 2015. Bruno Holthof is also Chair of the Board of Armonea, a European private care home provider.
Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations. He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.
EnQuest (ENQ.L) 19.7p £321.94m
Average Group production up 48% at 55,447 Boepd compared to 2017; above the mid-point of revised guidance
Strong performance at Magnus, with 100% interest delivering 21,528 Boepd in Dec, above expectations; high uptime, additional gas export and successful well interventions
Kraken average gross production of 30,310 Bopd was below expectations; reservoir performance remains on track with production limited by a combination of FPSO and weather related outages
Strong performance across other assets
Operating expenditure expected to be approximately $470m, with unit opex of c.$23/boe; SVT operating costs reduced by around 25% to approximately £150m
Cash capital expenditure was approximately $220m; below guidance of c.$250m primarily due to phasing from 2018 in to 2019
At 31 Dec 2018, net debt including PIK was approximately $1,774m with cash and available bank facilities of around $309m
Credit facility net debt/EBITDA ratio expected to be around 0.9x compared to future covenant threshold of 1.5x
2019 average Group production expected to grow by around 20% to between 63,000 Boepd and 70,000 Boepd
The Property Franchise Group (TPFG.L) 123.5p £31.37m
The Property Franchise Group, one of the UK’s largest property franchises, provided the following trading update for the year ended 31 Dec 2018, ahead of reporting its final results on 9 April 2019.
The Group performed well over the year with all its brands outperforming the market. Its hybrid brand, EweMove, traded profitably throughout the year and will show a significant improvement over FY17. Consequently, the Company expects to report trading for FY18 in line with market expectations and to show a material improvement on FY17 with enhanced margins.
Revenue increased by 10% to £11.2m (2017: £10.2m)
Management service fees (royalties) increased by 14% to £9.5m* (2017: £8.3m)
The Group was servicing c.55,000 tenanted managed properties at the year-end (2017: c.52,000)
Assisted acquisitions programme supported 28 acquisitions by franchisees (2017: 12) and added 3,115 managed properties (2017: 2,012)
Pay-per-click campaigns via the traditional high street brands’ customer websites delivered an 83% increase in leads to 30,474 (2017: 16,609)
Heavily weighted toward lettings, which accounts for 68% of Management Service Fees (2017: 70%)
A strong balance sheet, with net cash of £2.2m at the year-end
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.